Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Sarepta Therapeutics Appoints Michael Severino As Chief Executive Officer
PUBLIC · SRPTJul 27, 2026•13 days ago
Position
Chief Executive Officer
Company
Sarepta Therapeutics
Description
Sarepta Therapeutics, Inc. announced the appointment of Michael Severino, M.D., as chief executive officer, effective July 28, 2026. Severino, the former CEO of Tessera Therapeutics, will also join Sarepta’s Board of Directors.
Related People
Suggested for you
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months